Artificial intelligence and COVID-19: A multidisciplinary approach
- PMID: 32632356
- PMCID: PMC7255319
- DOI: 10.1016/j.imr.2020.100434
Artificial intelligence and COVID-19: A multidisciplinary approach
Abstract
The COVID-19 pandemic is taking a colossal toll in human suffering and lives. A significant amount of new scientific research and data sharing is underway due to the pandemic which is still rapidly spreading. There is now a growing amount of coronavirus related datasets as well as published papers that must be leveraged along with artificial intelligence (AI) to fight this pandemic by driving news approaches to drug discovery, vaccine development, and public awareness. AI can be used to mine this avalanche of new data and papers to extract new insights by cross-referencing papers and searching for patterns that AI algorithms could help discover new possible treatments or help in vaccine development. Drug discovery is not a trivial task and AI technologies like deep learning can help accelerate this process by helping predict which existing drugs, or brand-new drug-like molecules could treat COVID-19. AI techniques can also help disseminate vital information across the globe and reduce the spread of false information about COVID-19. The positive power and potential of AI must be harnessed in the fight to slow the spread of COVID-19 in order to save lives and limit the economic havoc due to this horrific disease.
Keywords: Artificial intelligence; COVID-19; Drug Discovery; Integrative medicine; Vaccine development.
© 2020 Korea Institute of Oriental Medicine. Publishing services by Elsevier B.V.
References
-
- Call to Action to the Tech Community on New Machine Readable COVID-19 Dataset. The White House. https://www.whitehouse.gov/briefings-statements/call-action-tech-communi.... Accessed March 24, 2020.
-
- ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). Identifier NCT03945825, Flublok or Fluzone With Advax-CpG55.2 or AF03; 2020 March 16 [cited 2020 March 23]; Available from: https://clinicaltrials.gov/ct2/show/NCT03945825?term=Advax&cond=infl....
-
- Park A. AI develops’ turbocharged’ flu vaccine: A clinical trial will soon be underway in the U.S. to test the efficacy of an enhanced flu vaccine developed by an artificial intelligence system at Flinders University in South Australia. Becker’s Hospital Review. https://www.beckershospitalreview.com/artificial-intelligence/ai-develop.... Accessed March 24, 2020.
-
- Smith M., Smith J.C. Repurposing therapeutics for COVID-19: Supercomputer-based docking to the SARS-CoV-2 viral Spike Protein and viral spike protein-human ACE2 interface. ChemRxiv. 2020 doi: 10.26434/chemrxiv.11871402.v4. - DOI
-
- Reicher M. Coronavirus call centers stumble in Washington state: glitches, lack of staff, contradicting messages. The Seattle Times. https://www.seattletimes.com/seattle-news/times-watchdog/washington-coro.... Published March 17, 2020. Accessed March 20, 2020.
Publication types
LinkOut - more resources
Full Text Sources